BAK:NYE-Braskem SA ADR (USD)

EQUITY | Chemicals | New York Stock Exchange

Last Closing

USD 4.05

Change

-0.01 (-0.25)%

Market Cap

USD 6.31B

Volume

1.18M

Analyst Target

USD 12.50
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Braskem SA is a petrochemical company. It produces a diversified portfolio of petrochemical and thermoplastic products, thermoplastic resins, including polyethylene, polypropylene and PVC.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-29 )

Largest Industry Peers for Chemicals

Symbol Name Price(Change) Market Cap
HUN Huntsman Corporation

-0.24 (-2.11%)

USD 2.32B
WLKP Westlake Chemical Partners LP

+0.07 (+0.32%)

USD 0.79B
TROX Tronox Holdings PLC

+0.58 (+11.37%)

USD 0.75B
ASIX AdvanSix Inc

-0.51 (-2.12%)

USD 0.62B
VHI Valhi Inc

-0.50 (-3.32%)

USD 0.43B
RYAM Rayonier Advanced Materials

-0.09 (-2.28%)

USD 0.26B
EVKIY Evonik Industries AG

-0.11 (-0.99%)

N/A
CE Celanese Corporation

-1.68 (-3.08%)

N/A
LXU Lsb Industries Inc

-0.02 (-0.26%)

N/A
DOW Dow Inc

-1.05 (-3.65%)

N/A

ETFs Containing BAK

FBZ First Trust Brazil AlphaD.. 0.00 % 0.80 %

-0.22 (-1.82%)

USD 6.05M
FLN First Trust Latin America.. 0.00 % 0.80 %

-0.35 (-1.82%)

USD 0.01B

Market Performance

  Market Performance vs. Industry/Classification (Chemicals) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.92% 100% F 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.92% 100% F 74% C
Trailing 12 Months  
Capital Gain -45.42% 45% F 5% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -45.42% 36% F 5% F
Trailing 5 Years  
Capital Gain -60.76% 9% A- 6% D-
Dividend Return 32.79% 57% F 77% C+
Total Return -27.96% 9% A- 10% F
Average Annual (5 Year Horizon)  
Capital Gain 0.32% 42% F 38% F
Dividend Return 4.59% 42% F 46% F
Total Return 4.27% 78% C+ 76% C+
Risk Return Profile  
Volatility (Standard Deviation) 73.89% 25% F 10% F
Risk Adjusted Return 6.21% 42% F 28% F
Market Capitalization 6.31B 86% B+ 62% D

Key Financial Ratios

  Ratio vs. Industry/Classification (Chemicals) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 10.10 71% 85%
Price/Book Ratio 181.02 14% 1%
Price / Cash Flow Ratio 0.59 100% 78%
Price/Free Cash Flow Ratio 35.37 14% 8%
Management Effectiveness  
Return on Equity -548.76% 14% 2%
Return on Invested Capital 10.74% 86% 69%
Return on Assets -0.61% 14% 19%
Debt to Equity Ratio -1,386.05% 100% 99%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector